BEVERLY HILLS, CA–(Marketwired – Feb 19, 2015) – Creative Edge Nutrition, Inc. (OTC PINK:FITX), a nutritional supplement company focusing on active lifestyles, is pleased to announce it has been asked to provide additional information to Health Canada in support of its application to operate under the federal government’s Medical Marijuana Purposes Regulations (MMPR).
The company is cooperating with Health Canada, as it has throughout the lengthy and rigorous application process. CEN Biotech Inc. is a Canadian company and Health Canada is on record as saying it does not divulge details about applications made under the MMPR, which is in keeping with Canada’s Privacy Act.
In this case however, key information contained in Health Canada’s written communication was passed to the media. CEN Biotech Inc. has contacted the Office of the Privacy Commissioner to ensure the corporation, staff, shareholders, and others within the MMPR continue to be protected under Federal Law.
Health Canada has both a right and an obligation to ask any and all questions of any applicant in this program. CEN Biotech Inc. has cooperated fully with all of Health Canada’s requirements to date and will continue to do so. It is making every effort to answer any and all questions to Health Canada’s satisfaction. In the interests of transparency and accountability the company will share what information it can with news media, shareholders, stakeholders and the public in general.
CEN Biotech Inc. looks forward to working with Health Canada and their officials to their complete satisfaction. The company hopes it can move forward to obtaining a license. This will help provide a much needed therapeutic drug, as mandated by the Supreme Court of Canada.
Press release inquiries:
Contact: Email: ir@Cenergynutrition.com
About Creative Edge Nutrition, Inc.
Creative Edge Nutrition, Inc. is a holding company and a Nutritional Supplement Company focused on developing innovative, high quality supplements and energy drinks. The company offers a broad spectrum of capsules, tablets, and powders, as well as science based products in the principal categories of weight management, nutrition challenges, energy and fitness. The Company manufactures under strict GMP guidelines at GMP Certified and/or FDA registered facilities. www.CenergyNutrition.com
The company is in the process of working with a PCAOB auditor for the spinout of CEN Biotech, Inc. Please visit the link below for CEN Biotech, Inc. videos.
As a “penny stock” Company, within the meaning of federal and state securities law, Creative Edge Nutrition, Inc. may not avail itself of the Safe Harbor provisions as identified in the Private Securities Litigation Reform Act of 1995. However, Creative Edge Nutrition, Inc. provides the following disclaimer and warning to protect our shareholders, prospective investors and the public at large by alerting them to the risks and uncertainties involved with any investment, and the need to perform their own due diligence and assessment.
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers.
Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Security and Exchange Commission.
Email: Email Contact